Literature DB >> 9750852

Standardizing cost-effectiveness analyses: the panel on cost-effectiveness in health and medicine.

M R Gold1.   

Abstract

Mesh：

Year:  1998        PMID： 9750852     DOI： 10.1016/s1076-6332(98)80352-8

Source DB:  PubMed          Journal:  Acad Radiol        ISSN： 1076-6332            Impact factor:   3.173


× No keyword cloud information.
  8 in total

1.  Twenty years of cost-effectiveness analysis in medical imaging: are we improving?

Authors:  Hansel J Otero; Frank J Rybicki; Dan Greenberg; Peter J Neumann
Journal:  Radiology       Date:  2008-12       Impact factor: 11.105

2.  Cost benefit analysis of mesh reinforcement of stapled left pancreatectomy.

Authors:  Kamran Idrees; Joshua R Edler; David C Linehan; Steven M Strasberg; David Jacques; Nicholas A Hamilton; Ryan C Fields; Dennis Lambert; Steven Kymes; William G Hawkins
Journal:  HPB (Oxford)       Date:  2013-02-20       Impact factor: 3.647

3.  Cost-effectiveness of an intervention to reduce HIV/STI incidence and promote condom use among female sex workers in the Mexico-US border region.

Authors:  José L Burgos; Julia A Gaebler; Steffanie A Strathdee; Remedios Lozada; Hugo Staines; Thomas L Patterson
Journal:  PLoS One       Date:  2010-06-30       Impact factor: 3.240

4.  Cost comparison of gastrojejunostomy versus duodenal stent placement for malignant gastric outlet obstruction.

Authors:  S M Jeurnink; S Polinder; E W Steyerberg; E J Kuipers; P D Siersema
Journal:  J Gastroenterol       Date:  2009-12-22       Impact factor: 7.527

5.  An integrated web-based mental health intervention of assessment-referral-care to reduce stress, anxiety, and depression in hospitalized pregnant women with medically high-risk pregnancies: a feasibility study protocol of hospital-based implementation.

Authors:  Dawn Kingston; Selikke Janes-Kelley; Janie Tyrrell; Lorna Clark; Deena Hamza; Penny Holmes; Cheryl Parkes; Nomagugu Moyo; Sheila McDonald; Marie-Paule Austin
Journal:  JMIR Res Protoc       Date:  2015-01-16

6.  Targeted screening and treatment for latent tuberculosis infection using QuantiFERON-TB Gold is cost-effective in Mexico.

Authors:  J L Burgos; J G Kahn; S A Strathdee; A Valencia-Mendoza; S Bautista-Arredondo; R Laniado-Laborin; R Castañeda; R Deiss; R S Garfein
Journal:  Int J Tuberc Lung Dis       Date:  2009-08       Impact factor: 3.427

7.  Cost-Effectiveness of Combined Sexual and Injection Risk Reduction Interventions among Female Sex Workers Who Inject Drugs in Two Very Distinct Mexican Border Cities.

Authors:  Jose L Burgos; Thomas L Patterson; Joshua S Graff-Zivin; James G Kahn; M Gudelia Rangel; M Remedios Lozada; Hugo Staines; Steffanie A Strathdee
Journal:  PLoS One       Date:  2016-02-18       Impact factor: 3.752

Review 8.  Screening for Hepatocellular Carcinoma in Chronic Hepatitis B: An Update.

Authors:  James Lok; Kosh Agarwal
Journal:  Viruses       Date:  2021-07-10       Impact factor: 5.048
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.